"10.1371_journal.pone.0065763","plos one","2013-06-18T00:00:00Z","Andrew C Adams; Carolyn A Halstead; Barbara C Hansen; Armando R Irizarry; Jennifer A Martin; Sharon R Myers; Vincent L Reynolds; Holly W Smith; Victor J Wroblewski; Alexei Kharitonenkov","Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America; Center for Preclinical Research, University of South Florida, Tampa, Florida, United States of America","Conceived and designed the experiments: AK BCH VLR SRM JAM HWS. Performed the experiments: CAH BCH ARI JAM HWS VJW. Analyzed the data: ACA CAH BCH ARI JAM SRM VLR HWS VJW AK. Contributed reagents/materials/analysis tools: CAH BCH ARI JAM SRM VLR HWS VJW. Wrote the paper: ACA AK.","The authors have the following interests: All authors of the manuscript except Barbara C. Hansen are employees of Eli Lilly and Company, the funder of this study. There are no ongoing clinical development studies with LY2405319. LY2405319 holds the following patents relating to material pertinent to this research: Christopher Carl Frye, Lihua Huang, Radmila Micanovic; WO 2006/028595 (US 7,582,607), filed July 26, 2005 (Eli Lilly and Company). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Barbara C. Hansen has no competing interests.","2013","06","Andrew C Adams","ACA",10,FALSE,6,6,10,2,TRUE,TRUE,FALSE,0,NA,FALSE
